Skip to main content

Annals of Hematology

Ausgabe 9/2022

Inhalt (35 Artikel)

Hemolytic anemia in COVID-19

Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ajeet Kaushik, Małgorzata Kujawska, Gaber El-Saber Batiha

Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence

  • Review Article

Sambhawana Bhandari, Maun Ranjan Baral, Matthew Barbery, Alla Rudinskaya, Oleg Sostin

Changes in hemoglobin and clinical outcomes drive improvements in fatigue, quality of life, and physical function in patients with paroxysmal nocturnal hemoglobinuria: post hoc analyses from the phase III PEGASUS study

  • Open Access
  • Original Article

David Cella, Sujata P. Sarda, Ray Hsieh, Jesse Fishman, Zalmai Hakimi, Kate Hoffman, Mohammed Al-Adhami, Jameel Nazir, Katelyn Cutts, William R. Lenderking

Thrombopoietin receptor agonist discontinuation rates and reasons among patients with immune thrombocytopenia: a study of administrative claims linked with medical chart review

  • Original Article

Adam Cuker, Lincy Lal, Anuja Roy, Caitlin Elliott, Maureen Carlyle, Carolyn Martin, Jens Haenig, Ricardo Viana

Adult Langerhans cell histiocytosis with thyroid gland involvement: clinical presentation, genomic analysis, and outcome

  • Original Article

Hua-cong Cai, Ting Liu, Hao Cai, Ming-hui Duan, Jian Li, Dao-bin Zhou, Xin-xin Cao

Frequency, pattern, and associations of renal iron accumulation in sickle/β-thalassemia patients

  • Original Article

Antonella Meloni, Luigi Barbuto, Laura Pistoia, Vincenzo Positano, Stefania Renne, Giuseppe Peritore, Priscilla Fina, Anna Spasiano, Massimo Allò, Giuseppe Messina, Tommaso Casini, Antonella Massa, Luigia Romano, Alessia Pepe, Filippo Cademartiri

Phenotypes of sickle cell intensive care admissions: an unsupervised machine learning approach in a single-center retrospective cohort

  • Original Article

Eduardo Messias Hirano Padrão, Brian Bustos, Ashwin Mahesh, Guilherme Henrique Hencklain Fonseca, Leandro Utino Taniguchi

An association between a positive direct antiglobulin test and HLA-DR12 in COVID-19

Hideaki Matsuura, Sumie Fujii, Yusuke Matsui, Yukari Sugiura, Hidehiko Akiyama, Yasuo Miura

Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria

  • Open Access
  • Original Article

Raymond S. M. Wong, Humphrey W. H. Pullon, Ismail Amine, Andrija Bogdanovic, Pascal Deschatelets, Cedric G. Francois, Kalina Ignatova, Surapol Issaragrisil, Pimjai Niparuck, Tontanai Numbenjapon, Eloy Roman, Jameela Sathar, Raymond Xu, Mohammed Al-Adhami, Lisa Tan, Eric Tse, Federico V. Grossi

Molecular characterization of triple-negative myeloproliferative neoplasms by next-generation sequencing

  • Original Article

Madhavi Maddali, Arvind Venkatraman, Uday Prakash Kulkarni, Sathya Mani, Santhosh Raj, Elanthenral Sigamani, Anu Korula, Fouzia N A, Sharon Anbumalar Lionel, Sushil Selvarajan, Marie Therese Manipadam, Aby Abraham, Biju George, Vikram Mathews, Poonkuzhali Balasubramanian

Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis

  • Original Article

Shai Shimony, Jonathan Canaani, Eitan Kugler, Boaz Nachmias, Ron Ram, Israel Henig, Avraham Frisch, Chezi Ganzel, Vladimir Vainstein, Yakir Moshe, Shlomzion Aumann, Moshe Yeshurun, Yishai Ofran, Pia Raanani, Ofir wolach

Correction to: Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real‑world, multi‑center, matched analysis

  • Correction

Shai Shimony, Jonathan Canaani, Eitan Kugler, Boaz Nachmias, Ron Ram, Israel Henig, Avraham Frisch, Chezi Ganzel, Vladimir Vainstein, Yakir Moshe, Shlomzion Aumann, Moshe Yeshurun, Yishai Ofran, Pia Raanani, Ofir wolach

Low cerebrospinal fluid-to-plasma ratios of orally administered lenalidomide mediated by its low cell membrane permeability in patients with hematologic malignancies

  • Original Article

Daisuke Ogiya, Norie Murayama, Yusuke Kamiya, Rie Saito, Sawako Shiraiwa, Rikio Suzuki, Shinichiro Machida, Kei Tazume, Kiyoshi Ando, Hiroshi Yamazaki

Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK/T-cell lymphoma

  • Original Article

Fei Qi, Yan Xie, Dedao Wang, Yue Chai, Bo Chen, Yan Sun, Weiping Liu, Shunan Qi, Yuce Wei, Hui Fang, Dan Zhao, Lin Gui, Yong Yang, Xiaoli Feng, Ning Ding, Lan Mi, Shaokun Shu, Yexiong Li, Yuqin Song, Mei Dong, Jun Zhu

Lowering platelet count threshold to 10,000/µL for peripherally inserted central catheter placement safely conserves blood products

  • Original Article

Roxana Amirahmadi, Scott Sullivan, Noel Britton, Ariel Siegel, Rory Spiegel, Jennifer Miceli, Vu Duong, Jeffrey T. Sholander, Magali J. Fontaine, Michael T. McCurdy

Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients

José Luis Piñana, Pablo Rodríguez-Belenguer, Dolores Caballero, Rodrigo Martino, Lucia Lopez-Corral, María-José Terol, Lourdes Vazquez, Marisa Calabuig, Gabriela Sanz-Linares, Francisca Marin-Jimenez, Carmen Alonso, Juan Montoro, Elena Ferrer, Ana Facal, María-Jesús Pascual, Alicia Rodriguez-Fernandez, María T. Olave, Almudena Cascales-Hernandez, Beatriz Gago, José-Ángel Hernández-Rivas, Lucia Villalon, Magdalena Corona, Alicia Roldán-Pérez, Julia Ribes-Amoros, Clara González-Santillana, Ramon Garcia-Sanz, David Navarro, Antonio J. Serrano-López, Ángel Cedillo, Emilio Soria-Olivas, Anna Sureda, Carlos Solano

Peripherally inserted central venous catheters decrease central line-associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score-adjusted analysis

  • Original Article

Yosuke Nakaya, Mika Imasaki, Michinori Shirano, Katsujun Shimizu, Naoko Yagi, Minako Tsutsumi, Masahiro Yoshida, Takuro Yoshimura, Yoshiki Hayashi, Takafumi Nakao, Takahisa Yamane

Correction to: Peripherally inserted central venous catheters decrease central line‑associated bloodstream infections and change microbiological epidemiology in adult hematology unit: a propensity score‑adjusted analysis

  • Correction

Yosuke Nakaya, Mika Imasaki, Michinori Shirano, Katsujun Shimizu, Naoko Yagi, Minako Tsutsumi, Masahiro Yoshida, Takuro Yoshimura, Yoshiki Hayashi, Takafumi Nakao, Takahisa Yamane

Hepatitis B reactivation during ruxolitinib treatment

  • Letter to the Editor

Marissa Sjoblom, Haithem Chtioui, Montserrat Fraga, Gregoire Stalder, Francesco Grandoni, Sabine Blum

Bortezomib-induced cardiogenic shock in a multiple myeloma patient with K light-chain cardiac amyloidosis

  • Letter to the Editor

Valentino Dammassa, Alessandra Greco, Rossana Totaro, Costanza Natalia Julia Colombo, Claudia Raineri, Rita Camporotondo, Gaetano Maria De Ferrari, Francesco Mojoli, Eloisa Arbustini, Luigi Oltrona Visconti, Guido Tavazzi

SARS-CoV-2 PrEP complicates antibody testing after vaccination: a call for awareness

  • Open Access
  • Letter to the Editor

Malte B. Monin, Benjamin Marx, Lisa Meffert, Christoph Boesecke, Jürgen K. Rockstroh, Christian P. Strassburg, Peter Brossart, Annkristin Heine

Neuroimaging of leptomeningeal myelomatosis: a rare and severe entity

  • Letter to the Editor

Teresa Perillo, Carmela Somma, Marianna Perrotta, Flavia Rivellini, Marialucia Barone, Andrea Manto

Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia

  • Letter to the Editor

Benjamin Podvin, Hélène Guermouche, Pauline Roynard, Laure Goursaud, Céline Berthon, Mahdi Ouafi, Elise Fourner, Nicolas Duployez, Olivier Nibourel, Catherine Roche-Lestienne

Increased blood levels of venetoclax due to intake of crushed venetoclax tablets

  • Letter to the Editor

Maiko Anzai, Takeo Yasu, Yoshito Gando, Mikio Shirota, Masayuki Kobayashi

Successful treatment of Kimura disease with benralizumab

  • Letter to the Editor

Vivian G. Szeto, Benjamin Chin-Yee, Mina Dehghani, Kamilia Rizkalla, Christopher Licskai, Cyrus C. Hsia

The rare IRF2BP2-RARA fusion in acute promyelocytic leukemia

  • Letter to the Editor

Xinhong Yang, Rongjuan Zhang, Zhihua Zhang

Severe platelet transfusion refractoriness due to anti-HPA-5a antibody during induction chemotherapy for acute promyelocytic leukemia

  • Letter to the Editor

Kei Saito, Satoshi Ichikawa, Rina Ohtomo, Shunsuke Hatta, Yuna Katsuoka, Hideo Harigae, Tohru Izumi

Understanding the EKG changes in methemoglobinemia

  • Letter to the Editor

Pramukh Arun Kumar, Mahati Dasari, Kamal Kant Sahu, Ibragim Al-Seykal, Ajay K. Mishra

Rhabdomyolysis induced by nelarabine

  • Open Access
  • Letter to the Editor

Christian Späth, Mandy Schönau, Sophie Gaubert, Thomas Neumann, Christian A. Schmidt, Florian H. Heidel, William H. Krüger

Serum levels of albumin and creatinine predict the outcome of sinusoidal obstruction syndrome after allogeneic HSCT

  • Letter to the Editor

Souichi Shiratori, Kohei Okada, Satomi Matsuoka, Shinichi Ito, Junichi Sugita, Takanori Teshima

Belantamab mafodotin in patients with relapsed/refractory AL amyloidosis with myeloma

  • Letter to the Editor

Yifei Zhang, Amandeep Godara, Stacey Pan, Denis Toskic, Hashim Mann, Douglas Sborov, Raymond Comenzo, Ankit Kansagra

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Innere Medizin

Vorhofflimmern: Antikoagulation vor Schlaganfall von Vorteil

Erleiden Menschen mit Vorhofflimmern einen ischämischen Schlaganfall, ist dieser weniger schwer, auch sind Infarktgröße und Blutungsrisiko geringer, wenn sie zuvor orale Antikoagulanzien erhalten haben. Die Art der Antikoagulation spielt dabei keine Rolle.

Frühe CLL-Therapie: BTK-Hemmer verlängert EFS und PFS, aber nicht OS

Auch nach sechs Jahren ergibt sich kein Überlebensvorteil einer Therapie mit dem BTK-Hemmer Ibrutinib für Menschen mit frühem CLL-Stadium und erhöhtem Progressionsrisiko. Die Progressionsrate wird mit der Behandlung jedoch um über 80% gesenkt.

Mehr Cholesterin im Essen = höheres Herzinfarktrisiko

Je mehr Cholesterin man täglich über die Nahrung zu sich nimmt, desto höher ist offenbar das Herzinfarktrisiko – das legt eine Studie mit US-Veteranen zumindest für Männer nahe.

Antikoagulation bei Vorhofflimmern: Sind DOAK noch zu toppen?

Gegen Thromboembolien so wirksam wie ein DOAK, bei zugleich geringerem Blutungsrisiko – werden Faktor-XI-Hemmer als neue Antikoagulanzien dieser Erwartung gerecht? Eine aktuell publizierte Vergleichsstudie gibt darüber Aufschluss.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.